Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - mometasone furoate monohydrate eqv mometasone furoate - spray, suspension - mometasone furoate monohydrate eqv mometasone furoate 0.05% w/v

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - epinephrine - solution for injection - epinephrine 1 mg/ml - epinephrine - epinephrine - adrenaline teva solution for injection is indicated in the following situations:– spasm of the airways in acute asthma attacks.– rapid relief of allergic reactions to drugs or other substances.– emergency treatment of anaphylactic shock.– cardiac arrest and cardiopulmonary resuscitation (physical measures should be used first).

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - budesonide (micronised); formoterol fumarate dihydrate (micronised) - powder, metered - budesonide (micronised) 160 mcg / inhalation; formoterol fumarate dihydrate (micronised) 4.5 mcg / inhalation

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - budesonide (micronised); formoterol fumarate dihydrate (micronised) - powder, metered - budesonide (micronised) 320 mcg / inhalation; formoterol fumarate dihydrate (micronised) 9 mcg / inhalation

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - etoposide - injection - 20 mg/ml - etoposide 20 mg/ml

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - oxaliplatin - infusion, solution concentrate - 5mg - oxaliplatin 5mg

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - doxorubicin hydrochloride - injection, solution, concentrate - doxorubicin hydrochloride 2mg/ml

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - mycophenolate mofetil - tablet, film coated - 500mg - mycophenolate mofetil 500mg

Israel - English - Ministry of Health

teva israel ltd - simvastatin - tablets - simvastatin 20 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvastatin-teva is indicated to: - reduce the risk of total mortality by reducing coronary death - reduce the risk of non-fatal myocardial infarction - reduce the risk for undergoing myocardial revascularization procedures. - reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvastatin-teva is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvastatin-teva therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertriglyceridemia (fredrickson type iv hyperlipidemia). simvastatin-teva is indicated for the treatment of patients with primary dysbetalipoproteinemia (fredrickson type iii hyperlipidemia).

Israel - English - Ministry of Health

teva israel ltd - simvastatin - tablets - simvastatin 10 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvastatin-teva is indicated to: - reduce the risk of total mortality by reducing coronary death - reduce the risk of non-fatal myocardial infarction - reduce the risk for undergoing myocardial revascularization procedures.- reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvastatin-teva is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvastatin-teva therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios.homozygous familial hypercholesterolemia: simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertriglyceridemia (fredrickson type iv hyperlipidemia). simvastatin-teva is indicated for the treatment of patients with primary dysbetalipoproteinemia (fredrickson type iii hyperlipidemia).